Design and rationale of a multicenter randomized trial assessing strategies for catheter ablation of persistent atrial fibrillation- The STAR AF 3 trial
Publication date: Available online 22 October 2026 Source: American Heart Journal Author(s): Laurent Macle, Frederic Sebag, Teiichi Yamane, Jean Champagne, Jose Romero, Daniel Scherr, Jean-François Roux, Marc W. Deyell, Hidemori Hayashi, Guy Amit, Mouhannad Sadek, Paul Novak, Peter M. Kistler, Massimo Grimaldi, Vidal Essebag, Alexandre Raymond-Paquin, Ivo Roca-Luque, Prashanthan Sanders, Paul Zei, Pablo Nery
Design and rationale of a multicenter randomized trial assessing strategies for catheter ablation of persistent atrial fibrillation- The STAR AF 3 trial. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002942?dgcid=rss_sd_all
Design and rationale of a multicenter randomized trial assessing strategies for catheter ablation of persistent atrial fibrillation- The STAR AF 3 trial. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326002942?dgcid=rss_sd_all
“Design and rationale of a multicenter randomized trial assessing strategies for catheter ablation of persistent atrial fibrillation- The STAR AF 3 trial.” American Journal of Kidney Diseases.
@article{article3309,
title = {Design and rationale of a multicenter randomized trial assessing strategies for catheter ablation of persistent atrial fibrillation- The STAR AF 3 trial},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002942?dgcid=rss_sd_all}
}